Condensed cyclic compound and organic light-emitting device including the same

US10367151B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10367151-B2
Application numberUS-201615012266-A
CountryUS
Kind codeB2
Filing dateFeb 1, 2016
Priority dateJun 23, 2015
Publication dateJul 30, 2019
Grant dateJul 30, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A condensed cyclic compound represented by Formula 1: wherein, in Formula 1, rings, groups and variables are the same as defined in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A condensed cyclic compound represented by one of Formulae 1A to 1D: L 1 to L 3 are each independently selected from the group consisting of a phenylene group, a fluorenylene group, a dibenzofuranylene group, and a dibenzothiophenylene group; and a substituted or unsubstituted phenylene group, a substituted or unsubstituted fluorenylene group, a substituted or unsubstituted dibenzofuranylene group, and substituted or unsubstituted a dibenzothiophenylene group, wherein each substituted group is substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a naphthyl group, a pyridinyl group, a fluorenyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, a1 to a3 are each independently an integer selected from 0 to 5, wherein when a1 is 2 or greater, two or more groups L 1 are identical to or different from each other, when a2 is 2 or greater, two or more groups L 2 are identical to or different from each other, and when a3 is 2 or greater, two or more groups L 3 are identical to or different from each other, R 1 to R 7 , and R 11 to R 18 are each independently selected from the group consisting of: a hydrogen, a deuterium, —F, a cyano group, a C 1 -C 10 alkyl group, and a C 1 -C 10 alkoxy group; a C 1 -C 10 alkyl group and a C 1 -C 10 alkoxy group, each substituted with at least one selected from a deuterium, —F, and a cyano group; a phenyl group, a pyridinyl group, a pyrimidinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; and a phenyl group, a pyridinyl group, a pyrimidinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from a deuterium, —F, a cyano group, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a pyridinyl group, a pyrimidinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, a group represented by is selected from groups consisting of groups represented by Formulae 5-1 to 5-60, and a group represented by is selected from groups consisting of groups represented by Formulae 5-1 to 5-69: wherein, in Formulae 5-1 to 5-69, * is a binding site to a neighboring atom. 2. The condensed cyclic compound of claim 1 , wherein L 1 to L 3 are each independently selected from groups consisting of groups represented by Formulae 3-1, 3-15, 3-28, and 3-41 to 3-56: wherein, in Formulae 3-1, 3-15, 3-28, and 3-41 to 3-56, Y 1 is selected from the group consisting of O, S, and C(Z 3 )(Z 4 ), Z 1 to Z 4 are each independently selected from the group consisting of a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a fluorenyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, d4 is an integer selected from 0 to 4, d3 is an integer selected from 0 to 3, and * and *′ are each a binding site to a neighboring atom. 3. The condensed cyclic compound of claim 2 , wherein i) a1 is 0; or ii) when a1 is not 0, at least one of groups Li is selected from groups consisting of groups represented by Formulae 3-15, 3-28, and 3-41 to 3-56. 4. The condensed cyclic compound of claim 2 , wherein L 1 is selected from groups consisting of groups represented by Formulae 3-15, 3-28, 3-41, and 3-51, L 2 and L 3 are each independently selected from groups consisting of groups represented by Formulae 3-1, 3-15, 3-28, 3-41, and 3-51, and a1 to a3 are each independently 0, 1, or 2. 5. The condensed cyclic compound of claim 1 , wherein a group represented by *-(L 1 ) a1 -*′ is selected from groups consisting of groups represented by Formulae 4-1 to 4-39: wherein, in Formulae 4-1 to 4-39, X 21 is C(Z 21 ), X 22 is C(Z 22 ), X 23 is C(Z 23 ), X 24 is C(Z 24 ), X 31 is C(Z 31 ), X 32 is C(Z 32 ), X 33 is C(Z 33 ), X 34 is C(Z 34 ), X 41 is C(Z 41 ), X 42 is C(Z 42 ), X 43 is C(Z 43 ), and X 44 is C(Z 44 ), Z 21 to Z 24 , Z 31 to Z 34 , and Z 41 to Z 44 are each independently selected from the group consisting of a hydrogen, a deuterium, a cyano group, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a fluorenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, * and * 1 are each a binding site to a neighboring atom. 6. The condensed cyclic compound of claim 1 , wherein at least one of R 3 , R 6 , R 13 , and R 16 is CN. 7. A condensed cyclic compound, being one of Compounds 1 to 271:

Assignees

Inventors

Classifications

  • containing three or more hetero rings · CPC title

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • containing organic luminescent materials · CPC title

  • Organic displays, e.g. OLED · CPC title

  • containing oxygen as the only heteroatom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10367151B2 cover?
A condensed cyclic compound represented by Formula 1: wherein, in Formula 1, rings, groups and variables are the same as defined in the specification.
Who is the assignee on this patent?
Samsung Electronics Co Ltd, Samsung Sdi Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D209/86. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).